Literature DB >> 20386096

Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations.

Meike B Zeimer1, Björn Padge, Britta Heimes, Daniel Pauleikhoff.   

Abstract

PURPOSE: Analysis and categorization of macular pigment (MP) distribution in type 2 idiopathic macular telangiectasia (IMT2) with regard to a possible grading scale for the severity of the disease.
METHODS: Nineteen IMT2 patients were examined including visual acuity (VA), fundus biomicroscopy, fluorescein angiography (FLA), microperimetry and optical coherence tomography (OCT). Distribution of MP was analyzed and categorized in MP density maps calculated from autofluorescence images obtained at 488 and 514 nm excitation wavelengths.
RESULTS: Typical features in MP density maps are in class I (n=8), a triangular segment of reduced MP in the temporal fovea and central accumulation of MP, class II (n=12), further expansion of the segment and vanishing of central accumulation, and class III (n=18), oval effacement of MP centrally, surrounding halo of MP at 5-7 degrees eccentricity. These classes were associated with the stages of the disease and increasing restrictions in visual function.
CONCLUSION: Association between changes in MP distribution, stages of IMT2 and restrictions in visual functions suggests that the classification of MP patterns reflects a severity scale for IMT2. Degenerative processes causing impairments in transport and storage of lutein (L) and zeaxanthin (Z) leading to secondary vascular changes may play a causative role in the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386096     DOI: 10.1097/IAE.0b013e3181bd2d38

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  17 in total

1.  [Morphological characteristics in macular telangiectasia type 2].

Authors:  P Charbel Issa; T F C Heeren; E Krüger; M Zeimer; D Pauleikhoff; F G Holz
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

2.  Spatial distribution of macular pigment estimated by autofluorescence imaging in elderly Japanese individuals.

Authors:  Akira Obana; Yuko Gohto; Hiroyuki Sasano; Werner Gellermann; Mohsen Sharifzadeh; Takahiko Seto; Paul S Bernstein
Journal:  Jpn J Ophthalmol       Date:  2020-01-27       Impact factor: 2.447

3.  ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Authors:  Ferenc B Sallo; Irene Leung; Meike Zeimer; Traci E Clemons; Adam M Dubis; Marcus Fruttiger; Daniel Pauleikhoff; Emily Y Chew; Catherine Egan; Tunde Peto; Alan C Bird
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

4.  The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia.

Authors:  Ferenc B Sallo; Tunde Peto; Catherine Egan; Ute E K Wolf-Schnurrbusch; Traci E Clemons; Mark C Gillies; Daniel Pauleikhoff; Gary S Rubin; Emily Y Chew; Alan C Bird
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-29       Impact factor: 4.799

Review 5.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

6.  Multifocal electroretinography in type 2 idiopathic macular telangiectasia.

Authors:  Raja Narayanan; Vivek Dave; Padmaja K Rani; Jay Chhablani; Harsha B Rao; Rajeev R Pappuru; Subhadra Jalali
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-06       Impact factor: 3.117

7.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

8.  Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Authors:  Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Ophthalmol Retina       Date:  2017-12-08

9.  MACULAR PIGMENT DISTRIBUTION RESPONSES TO HIGH-DOSE ZEAXANTHIN SUPPLEMENTATION IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2.

Authors:  Rene Y Choi; Aruna Gorusupudi; Kimberley Wegner; Mohsen Sharifzadeh; Werner Gellermann; Paul S Bernstein
Journal:  Retina       Date:  2017-12       Impact factor: 4.256

Review 10.  Imaging endpoints for clinical trials in MacTel type 2.

Authors:  Daniel Pauleikhoff; Laurenz Pauleikhoff; Emily Y Chew
Journal:  Eye (Lond)       Date:  2021-08-13       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.